Aristo Bio-Tech and Lifescience share price
NSE: ARISTOFertilizers & Agrochemicals
Aristo Bio-Tech and Lifescience Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jan 2023 · Issue price ₹72
Last close ₹86.00₹0.00 (0.00%)
Share price at the NSE close on 30 Oct 2026. Previous close ₹86.00.
30 Oct: open ₹86.00, high ₹86.00, low ₹86.00
52-week range of traded prices to 26 Oct 2026
₹74.30Low, 2 Apr 2026₹135.00High, 3 Nov 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. Market capitalisation: how it is worked out
- ₹59 Cr
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 8.15
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 1.32
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.70%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 17.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.80
- Volume, NSEVolume. Shares traded on the last trading day. Volume in the glossary
- 3,200
Results
Standalone; ₹ crore.Aristo Bio-Tech and Lifescience half-yearly results
- Revenue growth, 12 monthsRevenue growth, 12 months. The last twelve months against the twelve before them. Left empty where the earlier figure was nought or a loss: growth out of a loss has no percentage.
- +14.3%
- Net profit growth, 12 monthsNet profit growth, 12 months. The last twelve months against the twelve before them. Left empty where the earlier figure was nought or a loss: growth out of a loss has no percentage.
- +76.8%
Half year to Mar 2026, against the half year before
- RevenueRevenue. The pill is the change in revenue against the half year before: this period's figure divided by that one's, less one, in per cent.
- ₹107 Crdown 58.17%
- Net profitNet profit. The pill is the change in net profit against the half year before: this period's figure divided by that one's, less one, in per cent. Net profit in the glossary
- ₹3.01 Crdown 27.74%
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. Net margin in the glossary
- 2.8%
Revenue by half year
Peak revenue ₹256 Cr, half year to Sep 2025; lowest ₹89 Cr, half year to Mar 2023
Net profit by half year, a loss in red
- Net profit
- Loss
A loss in 1 of the 7 half years with results on record
| ₹ crore | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 129 | 89 | 133 | – | 214 | 104 | 256 | 107 |
| Net profit | 3 | 1 | 3 | – | 5 | 0 | 4 | 3 |
| Net margin | 2.0% | 1.1% | 1.9% | – | 2.1% | −0.5% | 1.6% | 2.8% |
Standalone. The 8 half years from Sep 2022, the first on record. The latest is shaded. No results on record for the half year to Mar 2024.
Year to Mar 2026, against the year before
- RevenueRevenue. The pill is the change in revenue against the year before: this period's figure divided by that one's, less one, in per cent.
- ₹364 Crup 14.34%
- Net profitNet profit. The pill is the change in net profit against the year before: this period's figure divided by that one's, less one, in per cent.
- ₹7.18 Crup 76.78%
- Net margin
- 2.0%
Revenue by year
Peak revenue ₹364 Cr, year to Mar 2026; lowest ₹218 Cr, year to Mar 2023
Net profit by year, a loss in red
| ₹ crore | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Revenue | 218 | – | 318 | 364 |
| Net profit | 4 | – | 4 | 7 |
| Net margin | 1.6% | – | 1.3% | 2.0% |
Standalone. Years to March. The latest is shaded. No results on record for the year to Mar 2024.
Business segments
In the year to Mar 2026 the company reports one business segment, Manufacturing,supply,Formulation etc of Agrochemical Products, which carries all its revenue.
Where the return came from
Yearly rates to Mar 2026, per-share figures restated for splits and bonuses.
| Over | Return a year | Earnings growth | Change in P/E | Dividend yield |
|---|---|---|---|---|
| 1 year | −34.7% | +76.7% | −63.5% | 0.8% |
| 3 years | +10.8% | – | – | 0.6% |
Return is price growth plus the average dividend yield. Change in P/E is (1 + price growth) / (1 + earnings growth) - 1, so the parts compound rather than add. Earnings growth and the change in P/E are left empty where earnings per share at either end of the window was a loss or is not on record.
Aristo Bio-Tech and Lifescience competitors and peers
Pesticides & Agrochemicals, 34 listed companies, priced on 29 Oct 2026. The table lists the 8 companies closest to Aristo Bio-Tech and Lifescience in market cap. Aristo Bio-Tech and Lifescience's own figures are from its last trade, on 26 Oct 2026.Chemical companies
Where the company sits among the companies nearest its size
| Company | ||||||||
|---|---|---|---|---|---|---|---|---|
 Indogulf CropsciencesIGCL | 370 | 9.59 | 0.81 | – | – | 10.5% | 9.7% | 0.00% |
 Sikko IndustriesSIKKO | 217 | 35.81 | 2.51 | – | – | 7.2% | 7.1% | 0.00% |
 Crop Life ScienceCLSL | 147 | 22.71 | 1.75 | +3.3% | +16.0% | 8.0% | 9.1% | 0.00% |
 Dhansa LabsDHANSA | 68 | – | – | – | – | – | – | 0.00% |
 Bhaskar AgrochemicalsBHASKAGR | 52 | – | 2.39 | +21.0% | – | – | 21.8% | 0.99% |
 Super Crop SafeSUCROSA | 50 | – | 1.59 | +43.3% | – | – | 4.7% | 0.00% |
 Aimco PesticidesAIMCOPEST | 38 | – | 2.17 | −37.9% | – | −42.4% | −36.0% | 0.00% |
 Shivchem AgroSHIVCHEM | 24 | – | – | – | – | – | – | 0.00% |
Market cap in ₹ crore. Growth is the last twelve months against the twelve before. A figure is left empty where it would rest on a loss or the company has under a year of results on record. ROE is the shareholders' profit over their net worth. ROCE is profit before interest and tax over the whole group's net worth plus borrowings, as in the figures at the top of the page.
Dividends
Per share, by the year it was paid for, and the latest payments.Aristo Bio-Tech and Lifescience dividend history
Dividend per share, ₹, restated for later splits and bonuses
Dividend per share. The dividends declared for the year, each restated to today's share count by the splits and bonuses after its own ex-date, added up. Dividend per share in the glossaryHighest ₹0.60 a share, year to Mar 2026.
| Ex-date | Type | Per share |
|---|---|---|
| 23 Sep 2026 | FinalFinal dividend. Called final by its date: the company did not say which kind it was, and it went ex within six months after the company's year end, the time in which the annual general meeting that declares the final dividend must be held. Final dividend in the glossary | ₹0.60 |
| 1 Sep 2025 | Final | ₹0.50 |
| 13 Sep 2024 | Final | ₹0.40 |
| 15 Sep 2023 | Final | ₹0.25 |
Latest payments, as declared, by ex-date.
Latest announcements
Routine notices left out.Aristo Bio-Tech and Lifescience announcements
Oct 2026
Sep 2026
Aristo Bio-Tech and Lifescience annual report, year to Mar 2026
Aristo Bio-Tech and Lifescience share price by year
Each calendar year to 2025.Aristo Bio-Tech and Lifescience share price history
| Year | Close at year end | Change | Highest close | Lowest close |
|---|---|---|---|---|
| 2025 | 120.00 | −9.8% | 146.00 | 88.10 |
| 2024 | 133.00 | +104.6% | 160.00 | 54.65 |
| 2023 | 65.00 | – | 92.80 | 52.40 |
₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before. 2023 is from its first session, 30 Jan 2023.
Recent sessions
The 9 trading days to 26 Oct 2026, as traded on NSE; the latest is at the top of the page.
| Date | Open | High | Low | Close | Average price | Volume | Delivery |
|---|---|---|---|---|---|---|---|
| 26 Oct 2026 | 85.00 | 86.00 | 85.00 | 86.00 | 85.90 | 8,000 | 100.0% |
| 23 Oct 2026 | 86.00 | 86.00 | 86.00 | 86.00 | 86.00 | 2,400 | 100.0% |
| 22 Oct 2026 | 89.00 | 89.00 | 88.20 | 88.20 | 88.52 | 4,000 | 100.0% |
| 21 Oct 2026 | 89.30 | 89.30 | 89.30 | 89.30 | 89.30 | 4,800 | 100.0% |
| 16 Oct 2026 | 89.30 | 89.30 | 89.30 | 89.30 | 89.30 | 1,600 | 100.0% |
| 8 Oct 2026 | 94.00 | 94.00 | 94.00 | 94.00 | 94.00 | 800 | 100.0% |
| 7 Oct 2026 | 94.00 | 94.00 | 94.00 | 94.00 | 94.00 | 800 | 100.0% |
| 6 Oct 2026 | 91.75 | 91.75 | 91.75 | 91.75 | 91.75 | 2,400 | 100.0% |
| 5 Oct 2026 | 87.40 | 87.40 | 87.40 | 87.40 | 87.40 | 1,600 | 100.0% |
Prices in ₹ per share as traded, not adjusted.
Company details
- NSE symbol
- ARISTO
- ISIN
- INE082101010
- Industry
- Fertilizers & Agrochemicals